Activist Beretta Proposes $44.80/Share Partial Tender Offer for 20.05% of Sturm, Ruger Shares
summarizeSummary
Activist investor Beretta Holding S.A. has formally proposed an all-cash partial tender offer to acquire an additional 20.05% of Sturm, Ruger & Co. shares at $44.80 per share, representing a significant premium. The offer is conditional on the Board exempting its poison pill.
check_boxKey Events
-
Proposed Partial Tender Offer
Beretta Holding S.A. proposes an all-cash partial tender offer to acquire up to an additional 20.05% of Sturm, Ruger's outstanding shares, which would increase their total beneficial ownership to 30%.
-
Premium Offer Price
The offer price is $44.80 per share, representing a significant premium of approximately 20% to the 60-day average price (VWAP).
-
Conditional on Poison Pill Exemption
The tender offer is conditional on Sturm, Ruger's Board granting an exemption to its "poison pill" rights plan, which was adopted on October 14, 2025.
-
Escalation of Activist Campaign
This proposal intensifies the ongoing proxy fight, with Beretta directly challenging the Board's defensive measures and offering a direct value proposition to shareholders, following a Schedule 13D/A filing earlier today.
auto_awesomeAnalysis
This filing marks a significant escalation in the ongoing proxy battle between Sturm, Ruger & Co. and activist investor Beretta Holding S.A. Beretta's proposal of a premium cash tender offer for a substantial portion of outstanding shares (up to 20.05%, bringing their total to 30%) directly challenges the Board's defensive "poison pill" strategy. For shareholders, this presents a concrete opportunity for liquidity at a premium, potentially forcing the Board to reconsider its stance or face increased pressure from investors. The outcome of the Board's decision regarding the poison pill exemption will be critical in determining the next steps in this high-stakes corporate governance conflict.
At the time of this filing, RGR was trading at $42.30 on NYSE in the Manufacturing sector, with a market capitalization of approximately $649.6M. The 52-week trading range was $28.33 to $48.21. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.